mLabs  Troponin I 

Evaluation for Myocardial Injury


High-sensitivity troponin I tests have shown great accuracy in determining a myocardial  infarction event (MI) in patients with chest pain, with triage times reduced to 1 hour, and also showed positive predictive ability, enabling safe discharge or rapid treatment initiation.


Micropoint's mLabs Troponin I test enables clinical staff to quickly rule out MI, and to help diagnose and monitor the effectiveness of treatment for heart attack and heart injury. The easy-to-use mLabs platform returns results after 8 minutes and uses whole blood samples without the need for centrifuges or laboratory equipment.


Clinical Applications:

  • Ruling out myocardial infarctions

  • Diagnosing and monitoring effectiveness of treatment


Troponin I Resources



Control Insert

Assay Insert Whole Blood

Assay Insert Plasma

Training Video


The mLabs Troponin I test is CE marked and distributed outside of the US.




To contact Micropoint to find out more or to purchase mLabs Troponin I test, please email:




U.S. Headquarters


Micropoint Bioscience, Inc.
3521 Leonard Court 
Santa Clara, CA 95054
United States


T:+1 (408) 588-1682
F:+1 (408) 588-1620



European Office


Micropoint Bioscience, Inc.

2 rue Eugene Sue

38100 Grenoble



T: +33 6 22 38 20 48

F: +33 4 76 09 03 50

Asian Office


Micropoint Biotechnologies Co., Ltd.

5F, Bldg 1

Runheng Dingfeng Industrial Park, Liuxian 2 Rd.

Shenzhen 518101, Guangdong



T: +86 755 21600849

F: +86 755 86673903

Copyright Micropoint Biosciences 2016

Micropoint Bioscience products are not available for sale nor marketed in the United States at this time.